U.S. Pharma Stock News

Elevance Health (NYSE:ELV) has signed new network participation agreements with Myomo, Inc. The deals extend in-network coverage for Myomo’s FDA cleared orthopedic devices to Elevance’s roughly 45 million Commercial, Medicare Advantage, and Medicaid members nationwide. For you as an investor, this ties directly into how NYSE:ELV positions itself as a broad based health benefits and services company. Elevance already spans commercial employer plans, government programs, and related health...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Transocean has completed an all stock acquisition of Valaris, combining two major offshore drilling companies. The deal significantly expands Transocean's offshore rig fleet and contract portfolio. Management expects cost synergies and a stronger competitive position in the global offshore drilling market. For investors watching NYSE:RIG, this merger follows a period of strong share price moves, with the stock up 48.8% year to date and 111.7% over the past year, closing at $6.31. The...

If you are wondering whether Preformed Line Products is still offering value after a strong run, this article walks through what the current share price might be implying about the business. The stock closed at US$267.23 recently, with returns of 4.6% over 7 days, a 2.5% decline over 30 days, 26.1% year to date and 118.3% over the past year, as well as 135.3% over 3 years and 271.3% over 5 years. Recent attention on grid reliability, utility infrastructure and related capital projects has...

Wells Fargo has filed a trademark application for "WFUSD," indicating potential plans to offer digital asset and cryptocurrency services. The filing points to possible products such as crypto trading, exchange services, payment processing, and digital asset wallets. This move would represent an expansion of Wells Fargo's role in the growing crypto and blockchain segment of financial services. Shares of Wells Fargo (NYSE:WFC) last closed at $76.88, with the stock showing a 14.0% return over...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

If you are wondering whether Amdocs is starting to look like value after a weaker share price, this article will help you weigh what the current price actually offers you. The stock last closed at US$66.92, with returns of a 2.6% decline over 7 days, an 8.8% decline over 30 days, a 16.5% decline year to date, and a 21.6% decline over the past year. Recent coverage around Amdocs has focused on its role as a software and services provider to telecom and media companies. This keeps attention on...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...

If you are wondering whether Microchip Technology is still good value after its recent run, this article will walk through what the current share price could mean for long term investors. The stock trades at US$65.79, with recent returns showing a 5.9% decline over 7 days, an 11.6% decline over 30 days, but a 30.6% gain over the past year and a 1.2% return year to date. Recent coverage around Microchip Technology has focused on its position in the semiconductor space and how investor...

Domo (DOMO) closed FY 2026 with fourth quarter revenue of US$79.6 million and a basic EPS loss of US$0.19, setting a clear snapshot of where the top line and bottom line currently stand. Over recent periods the company has kept quarterly revenue in a tight band around US$79 million to US$80 million, while basic EPS losses have ranged from US$0.25 to US$0.56 per quarter, giving investors a consistent read on how revenue scale and per share losses are tracking together. With that backdrop, this...

Afya: Stock Performance Snapshot After Recent Moves Afya (NasdaqGS:AFYA) has seen mixed share performance recently, with a 1-day return of about a 1% decline, a 3.3% gain over the past week, and weaker results over the past month and the past 3 months. See our latest analysis for Afya. With the share price at $13.88, Afya’s recent 7 day share price return of about 3% contrasts with weaker 1 month and year to date share price returns. Its 3 year total shareholder return of roughly 30% still...

If you are wondering whether FIGS is still good value after its recent run or if it is starting to look stretched, this article will walk through what the current price actually implies. FIGS trades at US$15.70 after a 46.2% return over the last 30 days, with year-to-date gains of 37.8% and a 1-year return of 237.6%, although the stock has slipped 7.5% over the past week. Recent market attention has centered on FIGS as investors reassess its position in the consumer durables space and...

HCA Healthcare (NYSE:HCA) has received the 2026 Patient Safety Excellence Award from Healthgrades for 92 of its hospitals. The recognition highlights strong performance on patient safety and quality metrics across a wide portion of HCA’s hospital network. This award follows earlier 2026 acknowledgments for several HCA facilities as top performers for quality and safety in the US hospital market. HCA Healthcare operates a large network of hospitals and outpatient facilities across the US, so...

Transaction Systems Services (TSS) closed its FY 2025 third quarter with revenue of US$41.9 million, Basic EPS of US$0.06 loss and net income excluding extra items of US$1.5 million loss. The trailing twelve months show revenue of US$234.8 million, Basic EPS of US$0.20 and net income of US$4.9 million. Over recent periods, the company has seen quarterly revenue move between US$12.2 million and US$99.0 million, with Basic EPS ranging from US$0.06 loss to US$0.13 per share. Net income excluding...

Pangaea Logistics Solutions (PANL) just wrapped up FY 2025 with fourth quarter revenue of US$183.9 million and basic EPS of US$0.19, alongside net income of US$11.9 million, in a context where trailing twelve month revenue is US$632.0 million and EPS is US$0.30. Over recent periods, the company’s quarterly revenue moved from US$147.2 million in Q4 2024 to US$183.9 million in Q4 2025. Over the same quarters, basic EPS shifted from US$0.18 to US$0.19. Investors may weigh these changes in...

Tidewater Inc. has reported its fourth quarter and full-year 2025 results, with Q4 revenue of US$336.8 million and a sharp increase in net income to US$219.88 million, alongside full-year revenue of US$1.35 billion and net income of US$334.66 million. Alongside these results, the company issued 2026 revenue guidance of US$1.43–US$1.48 billion, signaling management’s expectations for higher activity levels across its offshore support operations. Now we’ll examine how Tidewater’s stronger 2025...

Kodiak AI (KDK) just wrapped up FY 2025 with Q4 revenue of US$1.1 million and a basic EPS loss of US$0.42. The trailing twelve months show revenue of US$16.5 million and a basic EPS loss of US$5.74. The company reported TTM revenue of US$14.9 million in FY 2024, alongside a basic EPS loss of US$0.79, giving investors a clearer view of how the top line and per share losses have been tracking into this latest result and providing context for the 6.5% revenue growth figure reported over the past...

If you are wondering whether Science Applications International is attractively priced right now, you are not alone, especially with the stock sitting at US$91.60. The share price shows a 1.8% decline over the last 7 days, a 6.8% decline over 30 days, a 9.5% decline year to date and an 11.3% decline over 1 year. This contrasts with a modest 2.5% gain over 5 years and may be changing how investors think about its risk and return profile. Recent news coverage has focused on the company as a...

DexCom, Inc. recently announced that long-time leader Kevin R. Sayer has returned from a temporary leave to resume his role as Executive Chairman, while Rick Osterloh, a senior Google executive with deep consumer technology and AI experience, has joined the Board of Directors. These leadership moves strengthen DexCom’s board-level expertise in advanced hardware, software and artificial intelligence, potentially influencing how the company integrates digital health and consumer tech...

Why Arq’s halted GAC production matters for investors Arq (ARQ) has paused granular activated carbon production after independent testing highlighted equipment capacity limits. The company has idled its Corbin facility and recorded a non cash impairment charge tied to long lived assets in the fourth quarter of 2025. See our latest analysis for Arq. The halted GAC production, large non cash impairment and wider 2025 loss sit against a weak share price backdrop, with a 30 day share price return...

High Templar Tech (HTT) has put up a punchy set of FY 2025 numbers, with Q3 revenue of C¥8.5 million, basic EPS of C¥2.55 and trailing 12 month EPS of C¥4.86 backed by very large year over year earnings growth and an 18% net profit margin. The company has seen quarterly revenue shift from C¥55.0 million in Q3 2024 to C¥8.5 million in Q3 2025, while basic EPS moved from C¥0.73 to C¥2.55 over the same stretch. This sets up a results season where the key question is how durable this earnings...

Tredegar (TG) has posted its latest FY 2025 numbers with third quarter revenue at about US$194.9 million and basic EPS of roughly US$0.20, alongside trailing twelve month revenue of US$691.2 million and EPS of about US$0.07 that reflects the impact of a US$19.9 million one off loss. The company has seen quarterly revenue move from US$146.0 million in Q3 2024 to US$194.9 million in Q3 2025, while basic EPS has shifted from roughly a US$0.10 loss to about US$0.20. This gives investors a cleaner...

OppFi (OPFI) has delivered a sharp swing in its latest quarter, with Q3 2025 revenue of US$94.5 million and basic EPS of US$1.48, alongside net income of US$41.6 million. The company has reported revenue of US$75.3 million in Q2 2024, US$90.5 million in Q2 2025, and US$94.5 million in Q3 2025. Over the same periods, EPS moved from US$0.16 in Q2 2024 to a loss of US$0.78 in Q2 2025, before rebounding to US$1.48 in Q3 2025. This sets up a results season in which investors are likely to focus...